Ginossar Ventures

Illumex provides a generative semantic platform that optimizes structured data for analytics and governance in generative AI. The platform automatically analyzes metadata to discover, label, and add semantic meaning and business context without altering the underlying data. It offers data and analytics mapping, interpretation, and governance through a domain-specific AI engine that supports trustworthy, governed, and customized organizational large language models. By contextualizing organizational knowledge, Illumex helps enterprises harness big data for decision intelligence, promote data democratization, and improve return on investment.

Dig is a social video intelligence platform that helps brands monitor and manage their presence in the social video landscape. The platform analyzes brand-related social videos at scale, decoding billions of clips to reveal spoken words, visuals, captions, products, and narratives, enabling brands to identify negative trends, harmful content, or coordinated campaigns before they escalate and to seize opportunities to amplify favorable stories and refine products. It supports reputation protection and audience engagement in a video-first era, leveraging AI and GenAI to speed insights. The service also offers AI-powered content generation that compresses long-form video into engaging short clips and assists automatic editing, letting organizations decide what to share, when, and through which channels. By combining monitoring, analysis, and content optimization, Dig helps brands steer their video presence across platforms with greater confidence and agility.

DeepSurface is a Portland-based company specializing in risk-based vulnerability management. Its platform automates the analysis and prioritization of vulnerabilities by considering over 50 environmental attributes, enabling cybersecurity teams to predict potential damage and effectively manage risks.

Yonalink operates a global network comprising over 30,000 medical centers. It specializes in real-time collection of clinical trial data through its platform, which streamlines electronic health records (EHR) to electronic data capture (EDC), employs AI-driven case report form (CRF) data mapping, and facilitates secure, automated migration of research data from health records. This service enhances trial efficiency, improves data quality, reduces staff burnout at medical centers, and expands access to novel patient care opportunities. Additionally, the platform enables management of clinical trial operations and vendors, accelerates drug and device development, promotes patient diversity and enrollment, and ensures secure, fast, and error-free data capture processes for healthcare providers and researchers.